Serial 90701402
Live / Registered — Registered (as of 14 May 2024)
What this means for you
Registered since 14 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90701402
- Registration number
- 7388391
- Mark type
- Design / logo
- Filed
- 10 May 2021
- Published for opposition
- 15 Feb 2022
- Registered
- 14 May 2024
- Attorney of record
- Matthew P. Hintz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases
Owner
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
Prosecution history
- 14 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2024 — USE AMENDMENT FILED
- 05 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 01 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2023 — SOU EXTENSION 3 GRANTED
- 28 Jul 2023 — SOU EXTENSION 3 FILED
- 28 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 12 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2023 — SOU EXTENSION 2 GRANTED
- 10 Apr 2023 — SOU EXTENSION 2 FILED